In addition, in breast cancer cells, TRPC5 activation promotes autophagy and chemoresistance via the Ca2+/calmodulin-dependent protein kinase beta/adenosine monophosphate-activated protein kinase alpha/mechanistic target of rapamycin (CaMKKβ/AMPKα/mTOR) pathway [120]. This evidence concerns the gene MTOR and breast carcinoma.